Biosimilar Newsletter Archive

  1. 12.12.24 -- Is The BIOSECURE Act The First Real Step Toward Reshoring? 12/12/2024
    12/12/24 Biosimilar Development Newsletter
  2. 12.05.24 -- Filter Integrity Testing Annex 1 Requirements For Biologics DS 12/5/2024
    12/05/24 Biosimilar Development Newsletter
  3. 11.27.24 -- A Comprehensive Guide For Supplier Quality Agreements 11/27/2024
    11/27/24 Biosimilar Development Newsletter
  4. 11.21.24 -- Tips For Addressing Vaccine Demand – Strategies For C&G And mRNA 11/21/2024

    11/21/24 Biosimilar Development Newsletter

  5. 11.21.24 -- Safety Cabinets' Essential Role In EU GMP Annex 1 11/21/2024
    11/21/24 Biosimilar Development Newsletter
  6. 11.14.24 -- Take The Next Step Towards Scaling-Up 11/14/2024

    11/14/24 Biosimilar Development Newsletter

  7. 11.14.24 -- What's Next After FDA's DSCSA Extension? 11/14/2024
    11/14/24 Biosimilar Development Newsletter
  8. 11.07.24 -- Reduce Time To Market With Efficient Vial Selection 11/7/2024

    11/07/24 Biosimilar Development Newsletter

  9. 11.07.24 -- Data Quality Issues At The Heart Of FDA's DSCSA Troubles 11/7/2024
    11/07/24 Biosimilar Development Newsletter
  10. 10.31.24 -- Key Considerations For Aseptic Filling 10/31/2024

    10/31/24 Biosimilar Development Newsletter